DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $28,847 | +4.1% | 116,272 | +0.7% | 0.38% | +12.6% |
| Q2 2023 | $27,713 | -99.9% | 115,472 | -8.4% | 0.34% | -20.7% |
| Q1 2023 | $31,755,780 | -8.9% | 125,995 | -4.1% | 0.43% | -13.5% |
| Q4 2022 | $34,861,590 | -1.4% | 131,345 | -5.9% | 0.50% | +11.5% |
| Q3 2022 | $35,372,000 | -56.2% | 139,522 | -52.6% | 0.44% | -0.2% |
| Q2 2022 | $80,727,000 | +78.0% | 294,144 | +90.2% | 0.45% | -0.2% |
| Q1 2022 | $45,355,000 | -17.5% | 154,622 | -7.5% | 0.45% | -7.8% |
| Q4 2021 | $54,985,000 | +2.9% | 167,122 | -4.8% | 0.48% | -1.6% |
| Q3 2021 | $53,452,000 | +10.6% | 175,575 | -2.5% | 0.49% | +11.3% |
| Q2 2021 | $48,348,000 | +14.1% | 180,160 | -4.3% | 0.44% | +14.5% |
| Q1 2021 | $42,374,000 | +1.7% | 188,260 | +0.4% | 0.39% | -2.0% |
| Q4 2020 | $41,665,000 | -2.5% | 187,560 | -5.5% | 0.40% | -15.1% |
| Q3 2020 | $42,734,000 | +27.4% | 198,460 | +4.6% | 0.46% | +10.5% |
| Q2 2020 | $33,538,000 | +38.2% | 189,660 | +8.2% | 0.42% | +7.7% |
| Q1 2020 | $24,272,000 | -11.7% | 175,360 | -2.1% | 0.39% | +16.0% |
| Q4 2019 | $27,482,000 | -2.9% | 179,060 | -8.6% | 0.34% | -8.7% |
| Q3 2019 | $28,310,000 | +1.4% | 196,010 | +0.3% | 0.37% | +3.1% |
| Q2 2019 | $27,928,000 | +1.8% | 195,410 | -6.0% | 0.36% | +4.4% |
| Q1 2019 | $27,435,000 | +65.3% | 207,810 | +29.1% | 0.34% | +19.5% |
| Q4 2018 | $16,600,000 | -11.9% | 160,976 | -7.2% | 0.29% | +3.2% |
| Q3 2018 | $18,850,000 | +6.1% | 173,476 | -3.6% | 0.28% | +3.7% |
| Q2 2018 | $17,759,000 | +0.8% | 179,969 | +0.0% | 0.27% | -0.4% |
| Q1 2018 | $17,620,000 | +6.5% | 179,965 | +0.9% | 0.27% | +7.2% |
| Q4 2017 | $16,547,000 | +25.6% | 178,272 | +16.0% | 0.25% | 0.0% |
| Q3 2017 | $13,179,000 | +5.5% | 153,637 | +3.8% | 0.25% | -0.4% |
| Q2 2017 | $12,493,000 | +14.8% | 148,040 | +16.4% | 0.25% | -3.1% |
| Q1 2017 | $10,882,000 | +3.0% | 127,231 | -6.3% | 0.26% | +4.8% |
| Q4 2016 | $10,568,000 | -9.5% | 135,767 | -8.8% | 0.25% | -3.1% |
| Q3 2016 | $11,672,000 | -20.1% | 148,902 | +2.9% | 0.26% | -24.5% |
| Q2 2016 | $14,610,000 | +7.6% | 144,652 | +1.0% | 0.34% | +7.6% |
| Q1 2016 | $13,580,000 | +17.2% | 143,158 | +14.9% | 0.32% | +3.6% |
| Q4 2015 | $11,586,000 | +11.1% | 124,562 | +2.0% | 0.30% | +4.8% |
| Q3 2015 | $10,424,000 | -9.5% | 122,143 | -9.1% | 0.29% | +4.3% |
| Q2 2015 | $11,524,000 | -2.5% | 134,431 | -3.3% | 0.28% | +2.2% |
| Q1 2015 | $11,824,000 | -9.4% | 139,052 | -8.5% | 0.27% | -3.9% |
| Q4 2014 | $13,047,000 | +7.9% | 152,043 | -4.3% | 0.28% | +9.3% |
| Q3 2014 | $12,090,000 | -9.9% | 158,908 | -6.7% | 0.26% | -3.0% |
| Q2 2014 | $13,425,000 | +6.7% | 170,302 | +1.7% | 0.27% | +6.8% |
| Q1 2014 | $12,577,000 | +1.0% | 167,470 | +3.8% | 0.25% | -3.8% |
| Q4 2013 | $12,457,000 | +5.6% | 161,307 | -5.2% | 0.26% | +2.4% |
| Q3 2013 | $11,795,000 | +3.5% | 170,087 | -5.4% | 0.25% | +7.2% |
| Q2 2013 | $11,392,000 | – | 179,890 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |